As the Trump administration begins to make its mark on the Medicare drug price negotiation program and pursue its own policies on prescription drugs, litigation over program continues. In the two ...
As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ...
An appeals court has ruled against a legal challenge to the Drug Price Negotiation Program. On Wednesday, the U.S. Court of Appeals for the Sixth Circuit sided with the Department of Health and Human ...
Through this two-day program offered at Chicago Booth's Hong Kong campus, participants will gain an extensive set of negotiation tools, practice their skills, and benefit from valuable faculty and ...
Recently approved delays and exemptions to the CMS drug price negotiation program are projected to cost $8.8 billion over 10 years, according to a Congressional Budget Office report published Oct. 20.
“There is no protected property interest in selling goods to Medicare beneficiaries…at a price higher than what the government is willing to pay when it reimburses those costs.” – District Court for ...
John Wilkerson is a Washington correspondent for STAT who writes about the politics of health care. He is also the author of the twice-weekly D.C. Diagnosis newsletter. WASHINGTON — President Trump ...
The Centers for Medicare and Medicaid Services recently announced negotiated prices for 15 drugs, finalizing the second iteration of the Medicare Drug Price Negotiation Program. The first set of ...
As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely mentioned Medicare’s drug price negotiation program — even though the government is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback